Department of Urology, Hospital Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France.
Department of Urology, Hospital Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France.
Eur Urol. 2014 Mar;65(3):610-9. doi: 10.1016/j.eururo.2012.11.049. Epub 2012 Dec 1.
In spite of the increasing use of robot-assisted radical prostatectomy (RALP) worldwide, no level 1 evidence-based benefit favouring RALP versus pure laparoscopic approaches has been demonstrated in extraperitoneal laparoscopic procedures.
To compare the operative, functional, and oncologic outcomes between pure laparoscopic radical prostatectomy (LRP) and RALP.
DESIGN, SETTING, AND PARTICIPANTS: From 2001 to 2011, 2386 extraperitoneal LRPs were performed consecutively in cases of localised prostate cancers.
A total of 1377 LRPs and 1009 RALPs were performed using an extraperitoneal approach.
Patient demographics, surgical parameters, pathologic features, and functional outcomes were collected into a prospective database and compared between LRP and RALP. Biochemical recurrence-free survival was tested using the Kaplan-Meier method. Mean follow-up was 39 and 15.4 mo in the LRP and RALP groups, respectively.
Shorter durations of operative time and of hospital stay were reported in the RALP group compared with the LRP group (p<0.001) even beyond the 100 first cases. Mean blood loss was significantly lower in the RALP group (p<0.001). The overall rate and the severity of the complications did not differ between the two groups. In pT2 disease, lower rates of positive margins were reported in the RALP group (p=0.030; odds ratio [OR]: 0.396) in multivariable analyses. The surgical approach did not affect the continence recovery. Robot assistance was independently predictive for potency recovery (p=0.045; OR: 5.9). Survival analyses showed an equal oncologic control between the two groups. Limitations were the lack of randomisation and the short-term follow-up.
Robotic assistance using an extraperitoneal approach offers better results than pure laparoscopy in terms of operative time, blood loss, and hospital stay. The robotic approach independently improves the potency recovery but not the continence recovery. When strict indications of nerve-sparing techniques are respected, RALP gives better results than LRP in terms of surgical margins in pathologically organ-confined disease. Longer follow-up is justified to reach conclusions on oncologic outcomes.
尽管机器人辅助根治性前列腺切除术(RALP)在全球范围内的应用日益增多,但在腹膜外腹腔镜手术中,尚无 1 级循证医学证据表明 RALP 优于纯腹腔镜方法。
比较腹膜外腹腔镜下单纯腹腔镜根治性前列腺切除术(LRP)与 RALP 的手术、功能和肿瘤学结果。
设计、设置和参与者:2001 年至 2011 年,连续对 2386 例局限性前列腺癌患者进行了腹膜外 LRP。
共进行了 1377 例 LRP 和 1009 例 RALP,均采用腹膜外入路。
患者人口统计学、手术参数、病理特征和功能结果被收集到一个前瞻性数据库中,并在 LRP 和 RALP 之间进行比较。使用 Kaplan-Meier 方法测试生化无复发生存率。LRP 和 RALP 组的平均随访时间分别为 39 个月和 15.4 个月。
与 LRP 组相比,RALP 组的手术时间和住院时间更短(p<0.001),即使在 100 例首例患者之后也是如此。RALP 组的平均失血量明显较低(p<0.001)。两组的总体并发症发生率和严重程度没有差异。在 pT2 疾病中,多变量分析显示 RALP 组的阳性切缘率较低(p=0.030;比值比[OR]:0.396)。手术方法不影响控尿恢复。机器人辅助是勃起功能恢复的独立预测因素(p=0.045;OR:5.9)。生存分析显示两组的肿瘤控制结果相当。局限性在于缺乏随机分组和短期随访。
在手术时间、失血量和住院时间方面,采用腹膜外入路的机器人辅助术优于单纯腹腔镜手术。机器人辅助术独立提高了勃起功能恢复,但不影响控尿恢复。在严格遵守保留神经技术的适应证的情况下,RALP 在病理器官局限性疾病的手术切缘方面优于 LRP。需要更长时间的随访才能得出肿瘤学结果的结论。